Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harrison, M. J.
Right arrow Articles by Marshall, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harrison, M. J.
Right arrow Articles by Marshall, J.

Stroke, Vol 15, 441-442, Copyright © 1984 by American Heart Association


ARTICLES

Atrial fibrillation, TIAs and completed strokes

MJ Harrison and J Marshall

A retrospective survey of 1076 patients with completed strokes and 789 with transient ischemic attacks (TIAs) revealed that 5.6% of those with completed strokes but only 1.6% of those with TIAs were in atrial fibrillation. TIAs in the presence of atrial fibrillation tended to last longer than 60 minutes except in individuals who had coexistent carotid disease that might have been the source of their attacks. It is suggested that emboli from the fibrillating atrium rarely cause brief TIAs, and more usually cause 'long' TIAs or completed strokes.


This article has been cited by other articles:


Home page
HeartHome page
Y. L Bayard, S. H Ostermayer, and H. Sievert
Alternatives to warfarin in atrial fibrillation: drugs and devices
Heart, September 1, 2008; 94(9): 1113 - 1116.
[Full Text] [PDF]


Home page
StrokeHome page
R. G. Hart, L. A. Pearce, and P. J. Koudstaal
Transient Ischemic Attacks in Patients With Atrial Fibrillation: Implications for Secondary Prevention: The European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III Trial
Stroke, April 1, 2004; 35(4): 948 - 951.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D.C. Anderson, L.J. Kappelle, M. Eliasziw, V.L. Babikian, L.A. Pearce, H.J.M. Barnett, and J. Blakely
Occurrence of Hemispheric and Retinal Ischemia in Atrial Fibrillation Compared With Carotid Stenosis * Editorial Comment
Stroke, August 1, 2002; 33(8): 1963 - 1968.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. Saxena, S. Lewis, E. Berge, P. A.G. Sandercock, and P. J. Koudstaal
Risk of Early Death and Recurrent Stroke and Effect of Heparin in 3169 Patients With Acute Ischemic Stroke and Atrial Fibrillation in the International Stroke Trial
Stroke, October 1, 2001; 32(10): 2333 - 2337.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
P. J. Koudstaal and A. Koudstaal
Stroke Prevention in Patients With Atrial Fibrillation: What Have We Learned?
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1998; 3(1): 85 - 89.
[PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
B. N. Singh and B. Lopez
Atrial Fibrillation: Defining Some Unanswered Questions
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1998; 3(2): 195 - 199.
[PDF]


Home page
ANGIOLOGYHome page
K. F. Mortel and J. S. Meyer
Prospective Study of Vascular Events and Cerebral Perfusional Chang Following Transient Ischemic Attacks
Angiology, March 1, 1996; 47(3): 215 - 224.
[Abstract] [PDF]